Short interest in Emergent BioSolutions Inc (NYSE:EBS) increased during the last reporting period, rising from 7.09M to 8.14M. This put 18.25% of the company's publicly available shares short.

Emergent Media continues its successful partnership with VISIT FLORIDA with the debut of two new creator-led original video ...

America’s emergent interests in Greenland — natural resource extraction, new shipping lanes, expansion of our existing military presence at Pituffik Space Base — can all be realized within ...

Welcome to Emergent BioSolutions Inc. fourth quarter ... In the U.S., the public interest channel is backed by over $50 billion in opioid settlement funds from large pharma companies that are ...

During the last three months, 4 analysts shared their evaluations of Emergent BioSolutions EBS, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of ...

The Emergent site in question—which is equipped with multiple monoclonal antibody (mAb) manufacturing lines—is slated to boost Syngene’s total single-use bioreactor capacity to 50,000 liters ...